Both in Biotechnology
Intensity Therapeutics vs Pluri
Over the past year INTS returned −44.5% and PLUR returned −77.7%; their daily moves had a correlation of 0.07.
INTS −44.5% PLUR −77.7%Growth of $1, one year, split-adjusted
| Metric | INTS | PLUR |
|---|---|---|
| Price | $3.37 | $1.00 |
| Market cap | $11.0M | $12.3M |
| Today | −1.46% | −0.89% |
| 1 month | −20.0% | −32.0% |
| 6 months | −42.7% | −70.5% |
| Year to date | −67.1% | −66.6% |
| 1 year | −45.1% | — |
| Revenue growth (YoY) | — | −15.8% |
| Gross margin | — | 58.5% |
| Net margin | — | −1755.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 12.2× |
| Net cash | $9.5M | -$23.9M |
| Dividend yield | — | — |
| Volatility (60d) | 55.5% | 74.3% |
| Short % of float | 1.0% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).